EMA Panel Backs Filgotinib (Jyseleca) for Rheumatoid Arthritis EMA Panel Backs Filgotinib (Jyseleca) for Rheumatoid Arthritis

Filgotinib is an oral Janus kinase 1 inhibitor for adult patients with moderate to severe active RA who have responded inadequtely to or are intolerant of other therapies.International Approvals

Source: Medscape Today Headlines - July 29, 2020 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news